International Stem Cell (ISCO) Interest Coverage Ratio (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Interest Coverage Ratio of 2.85 for Q4 2025, up 117.59% year-over-year from 1.31 in Q4 2024, and up 1458.95% quarter-over-quarter from 0.18 in Q3 2025.
International Stem Cell (ISCO) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Interest Coverage Ratio for 16 consecutive years, with 2.85 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 117.59% year-over-year to 2.85; the TTM figure through Dec 2025 stood at 1.98 (up 126.18% YoY), while the FY2025 annual figure was 0.03, down 288.13% from the prior year.
- Interest Coverage Ratio grew to 2.85 in Q4 2025 per ISCO's latest filing, from 0.18 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 4.28 in Q4 2023 and bottomed at 10.42 in Q4 2021.
- Historically, Interest Coverage Ratio has averaged 1.3 across 5 years, with a median of 0.46 in 2022.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio soared 795.08% — and 2024, when it tumbled 3825.58%.
- International Stem Cell's Interest Coverage Ratio stood at 10.42 in 2021, then surged by 94.09% to 0.62 in 2022, then soared by 795.08% to 4.28 in 2023, then plunged by 69.47% to 1.31 in 2024, then soared by 117.59% to 2.85 in 2025.
- Business Quant data shows ISCO's Interest Coverage Ratio at 2.85 in Q4 2025, 0.18 in Q3 2025, and 0.27 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | -1.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Dec 31, 2025 | 2.85 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | 1.31 |
| Sep 30, 2024 | -2.57 |
| Jun 30, 2024 | 0.23 |
| Mar 31, 2024 | -2.07 |
| Dec 31, 2023 | 4.28 |
| Sep 30, 2023 | -2.85 |
| Jun 30, 2023 | -4.11 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | -8.57 |
| Jun 30, 2022 | 0.94 |
| Mar 31, 2022 | 0.74 |
| Dec 31, 2021 | -10.42 |
| Sep 30, 2021 | -1.98 |
| Jun 30, 2021 | -0.82 |